How FDA Disclosure Proposals Would Affect Industry
On May 19, 2010, the U.S. Food and Drug Administration's Transparency Task Force, chaired by Principal Deputy Commissioner Joshua Sharfstein, issued a report containing 21 specific proposals to improve agency transparency...To view the full article, register now.
Already a subscriber? Click here to view full article